| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |